Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy

INTRODUCTION: Sunitinib, a first-line therapy with a certain effect, was utilized in the early stages of renal cell carcinoma treatment. However, its clinical toxicity, side effects, and its limited bioavailability, resulted in inadequate clinical therapeutic efficacy. Building neoteric, simple, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xianhu, Teng, Yi, Zhu, Chunrong, Li, Zhipeng, Liu, Tian, Sun, Yong, Han, Shangcong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740013/
https://www.ncbi.nlm.nih.gov/pubmed/36510619
http://dx.doi.org/10.2147/IJN.S388234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740013/
https://www.ncbi.nlm.nih.gov/pubmed/36510619
http://dx.doi.org/10.2147/IJN.S388234

Ejemplares similares